Physician profile
Scott W Ecklund
NPI 1306892633
$283.90
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $23.33 · 2024: $76.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $51.66 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $44.20 | 2019 | |
| Novo Nordisk INC | $39.96 | 2019-2024 | Rybelsus, Ozempic |
| Daiichi Sankyo INC. | $26.42 | 2024 | Injectafer |
| Pfizer INC. | $23.07 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $22.70 | 2019 | |
| Radius Health, INC. | $19.30 | 2024 | Tymlos |
| Dynavax Technologies Corporation | $16.28 | 2024 | Heplisav-B |
| Grifols USA, LLC | $15.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.46 | 2019 | |
| Lilly USA, LLC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Ecklund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.